Bioadaptives (BDPT) Beginning Cash Balance (2015 - 2023)

Bioadaptives has disclosed Beginning Cash Balance across 4 years of filings, most recently posting $50000.0 for Q3 2023.

• Beginning Cash Balance for Q3 2023 came in at $50000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $50000.0 (changed 0.0% YoY), and the FY2023 annual result was $50000.0, up 2980.71% from the prior year.
• Beginning Cash Balance came in at $50000.0 for Q3 2023 at Bioadaptives, up from $1623.0 in the prior quarter.
• In the past five years, Beginning Cash Balance ranged from a high of $50000.0 in Q3 2023 to a low of $1623.0 in Q1 2021.
• The 3-year median for Beginning Cash Balance is $1623.0 (2021), against an average of $17748.7.
• Peak annual rise in Beginning Cash Balance reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
• Bioadaptives' Beginning Cash Balance stood at $1623.0 in 2021, then changed by 0.0% to $1623.0 in 2022, then surged by 2980.71% to $50000.0 in 2023.
• The last three Beginning Cash Balance figures came in at $50000.0 (Q3 2023), $1623.0 (Q1 2022), and $1623.0 (Q1 2021), per Business Quant data.